Sertraline
Sertraline Medical Valley contains the active substance sertraline. Sertraline belongs to a group of medicines called selective serotonin reuptake inhibitors (SSRIs); these medicines are used to treat depression and/or anxiety disorders.
Depression is a condition where you may feel sad, have difficulty sleeping or enjoying life.
OCD and panic disorder are anxiety-related conditions where you may feel anxious, have persistent thoughts (obsessions) that cause you to perform repetitive rituals (compulsive acts).
PTSD is a condition that can occur after a very traumatic experience and has symptoms similar to depression and anxiety.
Social anxiety disorder (social phobia) is an anxiety-related condition where you feel intense fear or anxiety in social situations (such as talking to strangers, speaking in front of a group of people, eating or drinking in front of others, or worrying about your potentially embarrassing behavior).
Your doctor has decided that this medicine is suitable for the treatment of your condition.
You should consult your doctor if you are unsure why you have been prescribed Sertraline Medical Valley.
Before taking Sertraline Medical Valley, you should discuss this with your doctor or pharmacist.
Medicines do not always suit everyone. You should tell your doctor before taking Sertraline Medical Valley if you have or have had any of the following conditions:
Children and adolescents under 18 years of age should not take Sertraline Medical Valley, except for patients with obsessive-compulsive disorder (OCD). In children and adolescents under 18 years of age, there is an increased risk of side effects such as suicidal attempts, suicidal thoughts, or hostility (mainly aggressive, defiant, and angry behavior) when taking medicines of this type. However, your doctor may decide to prescribe Sertraline Medical Valley to a patient under 18 years of age if it is in the patient's best interest. If your doctor prescribes Sertraline Medical Valley to a patient under 18 years of age and the child's caregiver wants to discuss this with them, they should contact the doctor. Furthermore, if any of the above symptoms appear or worsen while taking Sertraline Medical Valley, the caregiver should inform the doctor.
You should tell your doctor or pharmacist about all medicines you are taking now or have taken recently, as well as any medicines you plan to take, including those available without a prescription.
Some medicines may affect the way Sertraline Medical Valley works, or Sertraline Medical Valley may reduce the effectiveness of other medicines taken at the same time.
Taking Sertraline Medical Valley with the following medicines may cause serious side effects:
You should tell your doctor if you are taking any of the following medicines:
You should not drink alcohol while taking Sertraline Medical Valley.
Sertraline Medical Valley should not be taken with grapefruit juice, as it may increase the level of sertraline in the body.
If you are pregnant or breastfeeding, think you may be pregnant, or are planning to have a baby, you should consult your doctor or pharmacist before taking this medicine.
The safety of sertraline in pregnant women has not been fully established. Sertraline can only be used in pregnant women if the doctor considers that the benefits of the medicine outweigh the potential risks to the unborn child.
Taking Sertraline Medical Valley at the end of pregnancy may increase the risk of severe bleeding from the vagina, which can occur shortly after delivery, especially if you have a history of bleeding disorders. If you are taking Sertraline Medical Valley, you should inform your doctor or midwife so that they can give you appropriate advice.
Medicines like Sertraline Medical Valley, taken by women during the last three months of pregnancy, may increase the risk of a serious condition in the baby called persistent pulmonary hypertension of the newborn (PPHN), which causes rapid breathing and bluish skin. These symptoms usually appear in the first day of life. If such symptoms occur, you should contact the midwife and/or doctor immediately.
The baby may also experience other symptoms, usually within the first 24 hours after birth, including:
If your baby experiences any of these symptoms or if you are concerned about their health, you should contact the doctor or midwife, who will be able to advise you.
Sertraline passes into breast milk. The medicine can be used in breastfeeding women if the doctor considers that the benefits of the medicine outweigh the potential risks to the baby.
In animal studies, some medicines similar to sertraline have been shown to reduce sperm quality. This could theoretically affect fertility, although no effect on fertility has been observed in humans.
Psychotropic medicines like sertraline can affect your ability to drive or use machines. You should wait until you know how this medicine affects you before performing these activities.
The medicine contains less than 1 mmol (23 mg) of sodium per film-coated tablet, which means it is essentially "sodium-free".
This medicine should always be taken as directed by your doctor or pharmacist. If you are unsure, you should consult your doctor or pharmacist.
The usual effective dose for the treatment of depression and OCD is 50 mg/day. The daily dose can be increased gradually by 50 mg at intervals of at least one week over several weeks. The maximum recommended dose is 200 mg/day.
Treatment of panic disorder with or without agoraphobia, social phobia, and post-traumatic stress disorder should be started at a dose of 25 mg/day, increasing to 50 mg/day after one week. The daily dose can then be increased gradually by 50 mg at intervals of several weeks. The maximum recommended dose is 200 mg/day.
Sertraline Medical Valley can only be used in children and adolescents aged 6-17 years with obsessive-compulsive disorder (OCD).
Children aged 6-12 years:the recommended starting dose is 25 mg/day. After one week, the doctor may increase the dose to 50 mg/day. The maximum dose is 200 mg/day.
Adolescents aged 13-17 years:the recommended starting dose is 50 mg/day. The maximum dose is 200 mg/day.
Patients with liver or kidney disease should inform their doctor and follow their advice.
Method of administration:
Sertraline Medical Valley film-coated tablets can be taken with or without food.
The medicine should be taken once a day, in the morning or evening.
Your doctor will tell you how long you should take the medicine. The treatment period depends on the type of disease and the patient's response to treatment. Improvement of symptoms may start only after several weeks of treatment. Treatment of depression should usually be continued for 6 months after improvement.
If you accidentally take too much Sertraline Medical Valley, you should immediately contact your doctor or go to the emergency department of the nearest hospital.
You should always take the packaging and label with you, regardless of whether there is any medicine left in it or not.
Symptoms of overdose may include: drowsiness, nausea, and vomiting, rapid heartbeat, muscle tremors, agitation, dizziness, and in rare cases, loss of consciousness.
You should not take a double dose to make up for a missed dose. If you forget to take a tablet, you should not take the missed tablet. You should simply take the next tablet at the right time.
You should not stop taking Sertraline Medical Valley unless your doctor tells you to. Your doctor will advise you to gradually reduce the dose of Sertraline Medical Valley over several weeks before you finally stop taking it. If you suddenly stop taking the medicine, you may experience side effects such as dizziness, numbness, sleep disturbances, agitation or anxiety, headaches, nausea, vomiting, and muscle tremors. If you experience any of these side effects or any other side effects after stopping Sertraline Medical Valley, you should contact your doctor.
If you have any further questions about the use of this medicine, you should contact your doctor or pharmacist.
Like all medicines, this medicine can cause side effects, although not everybody gets them.
The most common side effect is nausea. Side effects depend on the dose and usually disappear or decrease as treatment continues.
If you experience any of the following symptoms after taking this medicine, as they can be serious.
If you experience yellowing of the skin and eyes, which may indicate liver damage.
The following side effects have been observed in clinical trials in adults and after the medicine was marketed:
visual disturbances
*Side effects reported after the medicine was marketed
In clinical trials with children and adolescents, side effects were generally similar to those in adults (see above). The most common side effects in children and adolescents were headaches, insomnia, diarrhea, and nausea.
After stopping this medicine, you may experience side effects such as dizziness, numbness, sleep disturbances, agitation or anxiety, headaches, nausea, vomiting, and muscle tremors (see section 3 "Stopping Sertraline Medical Valley").
There is an increased risk of fractures in patients taking medicines of this type.
If you experience any side effects, including any not listed in this leaflet, you should tell your doctor or pharmacist. Side effects can be reported directly to the Department of Drug Safety of the Office for Registration of Medicinal Products, Medical Devices, and Biocidal Products:
Jerozolimskie Avenue 181C, 02-222 Warsaw, phone: 22 49-21-301, fax: 22 49-21-309,
Website: https://smz.ezdrowie.gov.pl
Side effects can also be reported to the marketing authorization holder.
Reporting side effects will help to gather more information on the safety of this medicine.
The medicine should be stored out of sight and reach of children.
Do not use this medicine after the expiry date stated on the carton and blister after EXP.
The expiry date refers to the last day of the month.
Blister: Do not store above 25°C.
Bottle: No special storage precautions.
The active substance of the medicine is sertraline. Each tablet contains 50 mg, 100 mg, or 150 mg of sertraline (as sertraline hydrochloride).
The other ingredients of the medicine are:
Tablet core: microcrystalline cellulose (PH 101), sodium carboxymethylcellulose (type A), hydroxypropylcellulose-, calcium hydrogen phosphate, magnesium stearate.
Coating:
50 mg tablets (Opadry II Orange 85F93265)
Polyvinyl alcohol, partially hydrolyzed
Titanium dioxide (E 171)
Macrogol
Talc
Iron oxide yellow (E 172)
Iron oxide red (E 172)
100 mg tablets (Opadry II 85F18422 White):
Polyvinyl alcohol, partially hydrolyzed
Titanium dioxide (E 171)
Macrogol
Talc
150 mg tablets (Opadry II Blue 85F505120):
Polyvinyl alcohol, partially hydrolyzed
Titanium dioxide (E 171)
Macrogol
Talc
Indigo carmine, aluminum lake (E 132)
50 mg film-coated tablets: orange, oval, biconvex tablets with a score line on both sides of the tablet. The tablet dimensions are approximately 10 x 5 mm. The score line on the tablet is only for identification purposes and is not intended to divide the tablet into equal doses.
100 mg film-coated tablets: white, oval, biconvex, smooth tablets with dimensions of approximately 12 x 6 mm.
150 mg film-coated tablets: blue, oval, biconvex, smooth tablets with dimensions of approximately 13 x 8 mm.
Blister packs of PVC/Aluminum in a cardboard box.
50 mg tablets are available in packs of 20, 30, 50, 90, or 100 tablets.
100 mg tablets are available in packs of 20, 30, 50, or 100 tablets.
150 mg tablets are available in packs of 7 or 14 tablets.
A plastic bottle containing silica gel as a desiccant in a cardboard box.
50 mg tablets are available in packs of 30, 32, 90, 100, 105, 112, or 250 tablets.
100 mg tablets are available in packs of 30, 32, 90, 100, 105, 112, 210, or 250 tablets.
Not all pack sizes may be marketed.
Medical Valley Invest AB
Brädgårdsvägen 28
236 32 Höllviken
Sweden
email: safety@medicalvalley.se
Laboratorios Liconsa, S.A.
Avda. Miralcampo, Nº 7
Polígono Industrial Miralcampo
19200 Azuqueca de Henares (Guadalajara)
Spain
Denmark: Sertraline "Medical Valley"
Netherlands: Sertraline Xiromed 25 mg, 50 mg, 100 mg, 200 mg film-coated tablets
Iceland: Sertraline Medical Valley 25 mg, 50 mg, 100 mg, 150 mg, 200 mg film-coated tablets
Germany: Sertralin AXiromed 25 mg, 50 mg, 100 mg, 150 mg, 200 mg film-coated tablets
Norway: Sertraline Medical Valley
Poland: Sertraline Medical Valley
Sweden: Sertraline Medical Valley 25 mg, 50 mg, 100 mg, 150 mg, 200 mg film-coated tablets
Need help understanding this medicine or your symptoms? Online doctors can answer your questions and offer guidance.